Reuters
Reuters
@Reuters·4.2M subscribers·86.9K videos

Novo Nordisk to halve US list price of Wegovy in 2027

Posted

February 24, 2026

Views

15,110

Likes

14

Comments

2

Engagement

0.11%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Novo Nordisk will slash US list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 35% and 50% respectively starting next year, said the Danish drugmaker.

#novonordisk #wegovy #ozempic #health #News #Reuters #Newsfeed

Read the story here

👉 Subscribe

Keep up with the latest news from around the world

Follow Reuters on Facebook

Follow Reuters on Twitter

Follow Reuters on Instagram

Guests & Subjects Covered

Novo NordiskNews Reuters Newsfeed ReadSubscribe KeepFollow ReutersFacebook Follow ReutersTwitter Follow Reuters

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Novo Nordisk to halve US list price of Wegovy in 2027 · Reuters · Sentinel